Related Experiment Video

Updated: Apr 15, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.5K

Percutaneous treatment of aorto-ostial coronary lesions: Current challenges and future directions

Ronen Jaffe1, David A Halon1, Avinoam Shiran1

  • 1Department of Cardiology at the Lady Davis Carmel Medical Center, The Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

International Journal of Cardiology
|March 28, 2015
PubMed

Insights

Flow-limiting aorto-ostial coronary lesions impact large myocardial areas, causing significant ischemia. This review covers current knowledge and novel approaches for percutaneous coronary intervention in these challenging cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Coronary Artery Disease

Background:

  • Aorto-ostial coronary lesions are clinically significant due to the large myocardial territory they affect.
  • These lesions can induce extensive myocardial ischemia, posing diagnostic and therapeutic challenges.
  • Outcomes for aorto-ostial lesions are often inferior compared to non-ostial lesions.

Purpose of the Study:

  • To review and synthesize current knowledge on percutaneous coronary intervention (PCI) for aorto-ostial lesions.
  • To identify and propose novel strategies for improving procedural success and clinical outcomes.

Main Methods:

  • Comprehensive literature review of existing studies on aorto-ostial coronary lesions and PCI.
  • Analysis of diagnostic challenges and current treatment modalities.
  • Exploration of potential innovative techniques and approaches.

Main Results:

  • Aorto-ostial lesions present unique challenges in diagnosis and treatment.
  • Current PCI techniques for these lesions have limitations.
  • Further research into novel approaches is warranted to improve patient outcomes.

Conclusions:

  • Percutaneous coronary intervention for flow-limiting aorto-ostial lesions remains complex.
  • Optimizing PCI requires a thorough understanding of lesion characteristics and potential new strategies.
  • Future research should focus on developing and validating advanced techniques for these specific lesions.

Keywords:
Aorto-ostialCoronary artery diseaseGeographic missStent

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.3K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
623
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
452
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
621